WO1993005824A1 - Flexible member for medical use - Google Patents
Flexible member for medical use Download PDFInfo
- Publication number
- WO1993005824A1 WO1993005824A1 PCT/JP1992/000749 JP9200749W WO9305824A1 WO 1993005824 A1 WO1993005824 A1 WO 1993005824A1 JP 9200749 W JP9200749 W JP 9200749W WO 9305824 A1 WO9305824 A1 WO 9305824A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medical
- bag
- poly
- soft
- hydroxybutyrate
- Prior art date
Links
- 239000000463 material Substances 0.000 claims abstract description 51
- -1 lipid compound Chemical class 0.000 claims abstract description 38
- 229920001577 copolymer Polymers 0.000 claims abstract description 36
- 239000011342 resin composition Substances 0.000 claims abstract description 22
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims abstract description 17
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 238000001802 infusion Methods 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000004745 nonwoven fabric Substances 0.000 claims description 6
- 239000002759 woven fabric Substances 0.000 claims description 5
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 229920000739 poly(3-hydroxycarboxylic acid) polymer Polymers 0.000 claims description 2
- 238000000465 moulding Methods 0.000 abstract description 17
- 230000001954 sterilising effect Effects 0.000 abstract description 9
- 238000003912 environmental pollution Methods 0.000 abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 36
- 238000000034 method Methods 0.000 description 33
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 description 21
- 229920005989 resin Polymers 0.000 description 21
- 239000011347 resin Substances 0.000 description 21
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 16
- 241000700159 Rattus Species 0.000 description 16
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000008188 pellet Substances 0.000 description 12
- 239000002689 soil Substances 0.000 description 12
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 4
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical group OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 150000005690 diesters Chemical class 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 238000009940 knitting Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000007779 soft material Substances 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000736901 Thiocystis Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 2
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 2
- FMHKPLXYWVCLME-UHFFFAOYSA-N 4-hydroxy-valeric acid Chemical compound CC(O)CCC(O)=O FMHKPLXYWVCLME-UHFFFAOYSA-N 0.000 description 2
- PHOJOSOUIAQEDH-UHFFFAOYSA-N 5-hydroxypentanoic acid Chemical compound OCCCCC(O)=O PHOJOSOUIAQEDH-UHFFFAOYSA-N 0.000 description 2
- 241000589151 Azotobacter Species 0.000 description 2
- 241000588882 Beijerinckia Species 0.000 description 2
- 241001353638 Chlorogloea Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000721603 Mycoplana Species 0.000 description 2
- 241001495402 Nitrococcus Species 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 241000190967 Rhodospirillum Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241001554097 Thiopedia Species 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 241000589651 Zoogloea Species 0.000 description 2
- ACOGMWBDRJJKNB-UHFFFAOYSA-N acetic acid;ethene Chemical compound C=C.CC(O)=O ACOGMWBDRJJKNB-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- ALOUNLDAKADEEB-UHFFFAOYSA-N dimethyl sebacate Chemical compound COC(=O)CCCCCCCCC(=O)OC ALOUNLDAKADEEB-UHFFFAOYSA-N 0.000 description 2
- WOZVHXUHUFLZGK-UHFFFAOYSA-N dimethyl terephthalate Chemical compound COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- NUKZAGXMHTUAFE-UHFFFAOYSA-N methyl hexanoate Chemical compound CCCCCC(=O)OC NUKZAGXMHTUAFE-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000000807 solvent casting Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005979 thermal decomposition reaction Methods 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JFBCSFJKETUREV-UHFFFAOYSA-N 1,2 ditetradecanoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCC JFBCSFJKETUREV-UHFFFAOYSA-N 0.000 description 1
- DRUFTGMQJWWIOL-UHFFFAOYSA-N 1,2-dihexanoylglycerol Chemical compound CCCCCC(=O)OCC(CO)OC(=O)CCCCC DRUFTGMQJWWIOL-UHFFFAOYSA-N 0.000 description 1
- GFAZGHREJPXDMH-UHFFFAOYSA-N 1,3-dipalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC GFAZGHREJPXDMH-UHFFFAOYSA-N 0.000 description 1
- CNDHHGUSRIZDSL-UHFFFAOYSA-N 1-chlorooctane Chemical compound CCCCCCCCCl CNDHHGUSRIZDSL-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- RGMMREBHCYXQMA-UHFFFAOYSA-N 2-hydroxyheptanoic acid Chemical compound CCCCCC(O)C(O)=O RGMMREBHCYXQMA-UHFFFAOYSA-N 0.000 description 1
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical group CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 description 1
- JEMDXOYRWHZUCG-UHFFFAOYSA-N 2-octadecanoyloxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCCCCCCCC JEMDXOYRWHZUCG-UHFFFAOYSA-N 0.000 description 1
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 1
- HPMGFDVTYHWBAG-UHFFFAOYSA-N 3-hydroxyhexanoic acid Chemical compound CCCC(O)CC(O)=O HPMGFDVTYHWBAG-UHFFFAOYSA-N 0.000 description 1
- NDPLAKGOSZHTPH-UHFFFAOYSA-N 3-hydroxyoctanoic acid Chemical compound CCCCCC(O)CC(O)=O NDPLAKGOSZHTPH-UHFFFAOYSA-N 0.000 description 1
- ADFVYWCDAKWKPH-UHFFFAOYSA-N 4-ethoxycarbonylbenzoic acid Chemical compound CCOC(=O)C1=CC=C(C(O)=O)C=C1 ADFVYWCDAKWKPH-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000192705 Aphanothece Species 0.000 description 1
- 241000589941 Azospirillum Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 241000863012 Caulobacter Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 241001180360 Derxia Species 0.000 description 1
- 241000190986 Ectothiorhodospira Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- AALUCPRYHRPMAG-UHFFFAOYSA-N Glycerol 1-propanoate Chemical compound CCC(=O)OCC(O)CO AALUCPRYHRPMAG-UHFFFAOYSA-N 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000205062 Halobacterium Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001353956 Lamprocystis <gastropod> Species 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 241000862991 Leptothrix <Bacteria> Species 0.000 description 1
- 241000589323 Methylobacterium Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000605159 Nitrobacter Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241001057811 Paracoccus <mealybug> Species 0.000 description 1
- 241000287462 Phalacrocorax carbo Species 0.000 description 1
- 241000607568 Photobacterium Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000191025 Rhodobacter Species 0.000 description 1
- OSYQOBUUFRGFNG-UHFFFAOYSA-N Sebacic acid monomethyl ester Chemical compound COC(=O)CCCCCCCCC(O)=O OSYQOBUUFRGFNG-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000605008 Spirillum Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000606017 Syntrophomonas Species 0.000 description 1
- 241000521055 Thiodictyon Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920006167 biodegradable resin Polymers 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000008609 bushi Substances 0.000 description 1
- FACXGONDLDSNOE-UHFFFAOYSA-N buta-1,3-diene;styrene Chemical compound C=CC=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 FACXGONDLDSNOE-UHFFFAOYSA-N 0.000 description 1
- UTOVMEACOLCUCK-PLNGDYQASA-N butyl maleate Chemical compound CCCCOC(=O)\C=C/C(O)=O UTOVMEACOLCUCK-PLNGDYQASA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Polymers 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 229940014772 dimethyl sebacate Drugs 0.000 description 1
- JTYIUMFGUCLZHC-UHFFFAOYSA-N dioctyl benzene-1,2-dicarboxylate;phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O.CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC JTYIUMFGUCLZHC-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-L diphosphate(2-) Chemical compound OP([O-])(=O)OP(O)([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-L 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- JEJLGIQLPYYGEE-UHFFFAOYSA-N glycerol dipalmitate Natural products CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC JEJLGIQLPYYGEE-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229960002050 hydrofluoric acid Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- SNKMVYBWZDHJHE-UHFFFAOYSA-M lithium;dihydrogen phosphate Chemical compound [Li+].OP(O)([O-])=O SNKMVYBWZDHJHE-UHFFFAOYSA-M 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- RIEABXYBQSLTFR-UHFFFAOYSA-N monobutyrin Chemical compound CCCC(=O)OCC(O)CO RIEABXYBQSLTFR-UHFFFAOYSA-N 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- JQCXWCOOWVGKMT-UHFFFAOYSA-N phthalic acid diheptyl ester Natural products CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC JQCXWCOOWVGKMT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- XYGBKMMCQDZQOZ-UHFFFAOYSA-M sodium;4-hydroxybutanoate Chemical compound [Na+].OCCCC([O-])=O XYGBKMMCQDZQOZ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- RJIFVNWOLLIBJV-UHFFFAOYSA-N tributyl benzene-1,2,4-tricarboxylate Chemical compound CCCCOC(=O)C1=CC=C(C(=O)OCCCC)C(C(=O)OCCCC)=C1 RJIFVNWOLLIBJV-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical group CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 125000005591 trimellitate group Chemical group 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000002166 wet spinning Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
Definitions
- the present invention has biodegradability, flexibility, impact resistance, and processing.
- the present invention relates to a medical soft member having excellent physical properties in terms of properties and the like.
- polyvinyl chloride is used as a plasticizer
- a phthalic acid-based compound is used as a plasticizer, for example, dioctyl phthalate phthalate.
- elastomers such as styrene-butadiene-styrene type ABA type blocks
- Soft resin called coalescence is used
- Many medical soft members made of such materials, such as blood bags, tubes, and catheters, are disposable, and after being used for their respective purposes, are treated as waste. You. However, the above-mentioned medical soft materials do not decompose spontaneously and remain in their original form without being disintegrated for many years, causing various social problems such as
- biodegradable materials In response to these various problems, polymer materials that are degraded by natural ecosystems when discarded and left in the natural world, so-called biodegradable materials, have been widely studied and attracted attention in recent years.
- a biodegradable material As such a biodegradable material, a polymer material for the purpose of morphological collapse by mixing corn starch with propylene, polyethylene, etc. is known, but this only causes the shape to collapse over time. Since it does not involve the decomposition of high molecular backbones such as polypropylene and polyethylene, it is hardly a biodegradable material in an essential sense.
- poly (3-hydroxybutylate) produced by a certain kind of microorganism, or chemically synthesized, or a copolymer containing the same as a main component is known.
- Poly (3-hydroxy butylate) can be removed by leaving it in the natural environment. It has been confirmed that it is degraded well and has excellent biocompatibility, so it was expected to be applied to various fields such as medical applications.
- poly (3-hydroxybutyrate) is hard and brittle, it has physical properties problems such as poor impact resistance. Although it has thermoplasticity, it decomposes even near its melting point. Since the process began, the workability was poor, and the application could not be expanded widely. .
- poly (3-hydroxybutyrate) with other resin materials, for example, polyethylene oxide, ethylene propylene, polyacetate butyl, etc.
- poly (3-hydroxybutyrate) is mixed. Attempts have been made to improve These methods still have problems in stability, economy, processability, and the like of the resin composition obtained, and it is difficult to apply the resin composition to medical uses, which are particularly demanding in terms of safety and hygiene. Disclosure of the invention
- An object of the present invention is to solve the above-mentioned problems of the prior art.
- a predetermined resin composition as a material, it has excellent biodegradability, and is sterilized after use to landfill. Disposal in the sea or the sea and leaving it in the natural environment, it decomposes in a short time and does not cause environmental pollution, and is also excellent in processability, economy, ecosystem, biocompatibility, etc.
- An object is to provide a soft member.
- the present invention relates to a resin composition containing, as a main component, a polyhydroxyalkanoate, a copolymer thereof, or a mixture thereof, and containing 0.01 to 60% by weight of a lipid compound.
- a medical soft member characterized in that at least a part thereof is molded from a material containing the same.
- the polyhydroxyalkanoate is composed of poly (3-hydroxyalkanoate) and poly (4-hydroxyalkanoate). G), and bori (5—hydroxyalkanoate).
- the soft medical member preferably has a cylindrical shape, and more specifically, at least a part of any of an infusion set, a small transfusion set, a blood circuit, and a catheter is formed. preferable.
- the medical soft member preferably has a bag-like shape.
- the bag-like material is any of a blood bag, an infusion bag, a dialysate bag, and an enteral nutritional supplement bag. Is preferred.
- the medical soft member preferably has any of a thread shape, a woven fabric shape, and a nonwoven fabric shape. Specifically, a suture thread, a mesh, a patch, a breast, a prosthetic material, an adhesion It is preferred to use one of the prevention materials.
- FIG. 1 is a diagram showing the relationship between the number average molecular weight of poly (3-hydroxybutylene) and the dose of T-ray irradiation.
- FIG. 2 is a diagram showing the relationship between the number average molecular weight of borium (3-hydroxybutyrate) and the heat treatment time.
- FIG. 3 is a schematic view showing an example of a stable according to the soft medical material of the present invention.
- FIG. 4 is a schematic diagram showing an example of an infusion set to which a soft tube according to the soft medical material of the present invention is applied.
- FIG. 5 is a schematic view showing an example of a soft bag according to the soft medical material of the present invention.
- the medical soft member of the present invention includes a blood transfusion bag, an infusion bag, a dialysis fluid bag, an enteral nutritional supplement bag and the like, and various tubes, branch tubes, and catheters connected thereto, as described above.
- Various medical soft members made of soft materials such as poly (octyl chloride) added with dioctyl phthalate, etc., and thread and woven fabrics such as sutures, meshes, patches, briquettes, and prosthetic materials
- various medical soft members formed of non-woven fabrics and among medical soft members that are not brittle and require flexibility, such as stables and clips
- a variety of disposable medical soft members which are mainly composed of polyhydroxyalkanoate, a copolymer thereof, or a mixture thereof, and Composition containing 0.11 to 60% by weight of a crystalline compound, a composite material obtained by mixing the resin composition with another resin, a processed material comprising the resin composition and another resin material, and the like. It is at least partly formed.
- Such a medical soft member of the present invention has excellent productivity, flexibility, impact resistance, processability, economy, ecosystem and biocompatibility, and excellent biodegradability, and is inexpensive. And does not cause environmental pollution due to disposal.
- the soft member for medical use of the present invention basically comprises a polyhydroxylate, a copolymer thereof, or a mixture thereof as a main component, and contains 0.01 to 60% by weight of a lipid compound. It is formed from a resin composition having good biodegradability.
- Examples of applicable polyhydroxyalkanoates include those having about 3 to 12 carbon atoms as a repeating unit of hydroxyalkanoate.
- Poly (4-hydroxy lucanoate) such as poly (3-hydroxy butanoate), poly (3-hydroxy butyrate), poly (3-hydroxy valerate), poly (3-hydroxy octanoate), and poly (4) Bol (4-hydroxyalkanoate), such as hydroxypropylate and poly (4-hydroxyvalerate), and poly Borys (5-hydroxyal kanoates) such as (5-hydroxyvalerate) are preferably applied.
- poly (3-hydroxybutyrate) is suitably applied.
- copolymer of polyhydroxyalkanoate examples include copolymers of 3-hydroxybutyrate and other hydroxyalkanoates having 3 to 12 carbon atoms. Specifically, ( 3- (hydroxybutyrate) 1- (3-hydroxypropionate) copolymer, (3—hydroxybutyrate) 1- (3—hydroxypropionate) 1- (4-hydroxybutyrate) Kobolima (3-Hydroxybutyrate) 1- (3-hydroxyvalerate) copolymer, (3-hydroxybutyrate) 1- (3-hydroxypallylate) 1- (3-hydroxyhexanoate) 1 ( 3- (hydroxyheptanoate) copolymer, (3-hydroxybutyrate) 1- (3-hydroxyvalerate) 1- (3-hydroxyhexano) (Ethyl) 1 (3—Hydroxyheptanoe) 1 (3—Hydroxyoctanoe) Copolymer, (3—Hydroxybutyrate) 1 (3—Hydroxyhexanoate) -(3-Hyd
- a mixture of the above-mentioned polyhydroxyl ethers, a mixture of the above-mentioned copolymers, and a mixture of both are also suitably applicable.
- these polyhydroxyalkanoates and copolymers thereof are produced by various microorganisms, but in the present invention, they may be produced by any of them.
- microorganisms that produce polydanidroxyalkanoate include, for example, Acinetobacter, Acinetomycetes (Act inomycetes), and Alcaligenes. es], Aphanothece, Aquas piri lura, Azospirillum, Azotobacter, Azotobacter, Baci l lus, Begiatolua Beggiat oa], Beijerinckia [Beijerinckia], Korono, Caulo bacter, Chloroflex [Chlorofrexeus], Chlorogloea [Chlorogloea], Chromatim [Chro raat i um], Chromosome [Chromobacteriura], Clostridium [Clostridum], Derxia, Dextria [Ectot hiorhodospira], Escherichia [Echerichia], Ferrono Chileles [Ferrobacillus], Geriaphos Haemophilus,
- Examples are various bacteria belonging to
- the number-average molecular weight Mn of the polyhydroxylated carbonate synthesized by fermentation in this way and its copolymer is usually about 3,000,000 to 3,000,000000. Also, those obtained by reducing the molecular weight by, for example, heat treatment or X-ray treatment after fermentation synthesis to have a molecular weight of, for example, about 3,000 to 10,000 can be suitably used.
- the 3-hydroxyalkanoate and / or 4-hydroxyalkanoate having a number average molecular weight of 10,000 to 200,000, preferably 30,000 to 100,000 ( / 3-Or Ryo-Hydro
- xylalkanoate As the main component, the mechanical strength due to hydrolysis in the living body and the disappearance of the material itself can be reduced from several months to several years, and sutures, prosthetic materials, adhesions It can be suitably used as a soft medical member for implanting in a living body that needs to maintain its action for a long period of time, such as an inhibitor.
- the number average molecular weight is more than 200,000, it takes a long time to reduce mechanical properties due to hydrolysis in the living body, and the implantable material for medical use In fact, the decomposition is inadequate during use. On the other hand, if it is less than 10,000, the strength as an embedding material is lost.
- the molecular weight can be adjusted by, for example, a post-treatment such as heat treatment or X-ray treatment.
- the molecular weight of polyhydroxyalkanoates is reduced by irradiation with ionizing radiation, particularly radiation.
- Figure 1 shows the change in the number-average molecular weight when poly (3—hydroxy butylate), a kind of poly (0—hydroxyalkanoate), is irradiated with X-rays from cobalt 60 as a source.
- the results show that the number average molecular weight, which was 275,000 before X-ray irradiation, decreased with increasing irradiation dose, and decreased to 20,000, and 1 Z 10 or less by 1 OM rad irradiation. Using this relationship, the number average before processing ⁇ ⁇ ⁇ It can be seen that the molecular weight can be reduced to an arbitrary molecular weight by controlling the irradiation dose of X-rays regardless of the molecular weight.
- poly (3-hydroxybutyrate) has a melting point at 180 ° C, but at temperatures above about 160 ° C, thermal decomposition occurs with a decrease in molecular weight.
- Figure 2 shows the relationship between the heat treatment time and the number average molecular weight of poly (3-hydroxybutyrate). According to this, it can be seen that the number average molecular weight decreases to about 1 Z4 when treated at 175 ° C. for 20 minutes, and to about 12 when further treated at 190 ° C. for 1 minute.
- the molecular weight can be controlled to an arbitrary value and reduced as in the case of X-ray irradiation.
- poly (3) is used in acid solutions such as sulfuric acid, salt fe, hypozinc acid, and perchloric acid, and in alkaline solutions such as sodium hydroxide and potassium hydroxide. —Or 4-hydroxy alcoholic acid)
- acid solutions such as sulfuric acid, salt fe, hypozinc acid, and perchloric acid
- alkaline solutions such as sodium hydroxide and potassium hydroxide.
- 4-hydroxy alcoholic acid As a result, the molecular weight is reduced, and as a result, by appropriately selecting the processing conditions, it is possible to control so as to obtain an arbitrary number average molecular weight, that is, an arbitrary biodegradation time.
- Yeast extract (DIFC 0) 1 g, Polypeptone (Nippon Yakuhin) 1 g, Meat extract (Kyokuto Pharmaceutical) 0.5 g, Ammonium sulfate (Wako Pure Chemical) 0.5 g was dissolved in 100 mL of distilled water and placed in a 500 mL Sakaguchi flask.
- a seed strain of Alcaligenes eutrophus HI 6 (ATCC 176999) was inoculated, cultured with a cotton plug and shaken at 30 ° C for 2 days. The bacteria that grew for 1.0 Sakaguchi flask were collected by centrifugation at 600 rpm for 15 minutes.
- the medium was placed in 2.6 1 Jarf Armen Yuichi (manufactured by Marubishi Biohenge), and the previously collected cells were transferred to 30 ° C and the number of stirring blades
- the cells were cultured for 48 hours under the conditions of 500 rpm and an aeration rate of 1 ml / rain. After the completion of the culture, the cells were collected by centrifugation at 600 rpm for 15 minutes, washed with water, and lyophilized.
- the obtained dried bacterial cells (11.2 g) were placed in a 2-litre black-mouthed form and stirred at room temperature for 24 hours to extract the polymer, and the extract was filtered to remove insoluble bacterial components. About 10 times the amount of n-hexane (reagent first grade, manufactured by Wako Pure Chemical Industries, Ltd.) was added dropwise to precipitate the polymer. This polymer is poly (3-hydroxybutyrate).
- H-NHR JEOL's nuclear magnetic resonance spectrometer EX-90.
- the number average molecular weight measured by gel chromatography was 775,000. When this was irradiated with 10 Mrad of ⁇ -rays using cobalt 60 as a radiation source, the number average molecular weight was 80,000.
- the boron (3-hydroxybutyrate) synthesized in Experimental Example 2 was left in an oven at 190 ° C. for 10 minutes to perform a heat treatment. As a result, the number average molecular weight was 120,00.0.
- the polymers obtained in Experimental Examples 1 to 5 were molded into a film of about 50 wm in thickness and 1 x 1 cm by the solvent casting method, sterilized with ethylene oxide gas, and then implanted under the back of the rat. Then, one year later, it was taken out and observed.
- Table 3 shows the predicted molecular weight and the estimated time to decrease in mechanical strength after one year. It takes 5 years to reduce the mechanical strength. Practically somewhat long. In addition, it takes 10 to several decades for this material to completely disappear without debris (become soluble in water), and there are many problems in use. Table 3
- This pellet was extruded from a nozzle with an inner diameter of 0.5 mm ⁇ using a small-sized small extruder (manufactured by Ooba Seisakusho) at a molding temperature of 178 C at a part of the cylinder and a die temperature of 176, and a thread-shaped one was obtained. Obtained. This was immediately quenched with liquid nitrogen. Thereafter, the film was slowly (manually) stretched 10 times or more by a stretching apparatus until immediately before breaking at room temperature (about 29 ° C). Then, heat treatment was performed in an oven at 60 ° C. for 3 hours. As a result, a flexible yarn having an outer diameter of 0.10 mm was obtained.
- Example 4 A yarn was obtained in the same manner as in Example 6 using the 3-hydroxybutyrate / 3-hydroxyvalerate copolymer (number-average molecular weight 50,000) treated in Example 5. Further, the rat back skin was sutured similarly to the suture needle, but there was no particular problem. I (Experimental example 4)
- 3-Hydroxyl oxybutyrate treated in Experimental Example 4 A xiptilate copolymer (number average molecular weight 182,000) was formed into a 0.3 mm thick film by solvent casting using chloroform. It was cut into 30 mm x 30 mm, and inserted between the wound in the abdominal cavity of the rat and the intestine to observe its function as an anti-adhesion membrane. One month later, the wound was almost completely healed, and no adhesion was found between the wound and internal organs. The film remained almost intact.
- a yarn with an outer diameter of 0.01 to 0.03 mm0 was obtained in the same manner as in Experimental Example 6, except that the die was formed using an extruder in which the diameter was changed to a 6-hole multi-hole with a diameter of 0.3 mm.
- the resin composition applied to the medical soft member of the present invention contains such a polyhydroxyalkanoate or a copolymer thereof as a main component, and contains a lipid compound in an amount of 0.01 to 6%. It contains 0% by weight.
- Examples of the lipid compound to be blended with the polyhydroxyalkanoate used in the resin composition of the present invention include monoglycerides, diglycerides, triglycerides, monocarboxylic esters, dicarboxylic monoesters, dicarboxylic diesters, dialcohols. Examples thereof include one or more of monoester, dialcohol diester, tricarboxylic acid monoester, tricarboxylic acid diester, and tricarboxylic acid triester.
- monoglycerides include glycerol monoacetate, glycerol monopropionate, glycerol monobutyrate, glycerol monoproate, glycerol monolaurate, glycerol monopalmitate, glycerol monopalmitate and glycerol monostearate Glycerol diacetate, glycerol dibutionate pionate, glycerol dibutylate, glycerol dicaproate, glycerol dilulaurate, glycerol dimyristate, glycerol dipalmitate, glycerol Roll distearate, etc .;
- Is a door re-glycerin Li De glycerol door Li Asete door, grayed Li Seroru Bok Li professional Pione Bok, glycerol Bok Li butyrate, single-door, glycerol door 1) force Puroe door, glycerol door Li La cormorant rate Glycerol tripalmitate, glycerol trimiristate, glycerol tristearate, etc .;
- carboxylic acid esters examples include esters composed of a carboxylic acid having 2 to 30 carbon atoms and an alkyl alcohol having 2 to 30 carbon atoms. Specifically, a saturated or unsaturated monocarboxylic acid is used.
- rubonic esters include n-amyl acetate, ethyl propionate, methyl caproate, ethyl ethyl crotnate, and n-butyl oleate;
- saturated or unsaturated dicarboxylic acid monoester examples include monomethyl sebacate, mono-n-butyl maleate, and monoethyl terephthalate;
- Saturated or unsaturated dicarboxylic diesters include dimethyl sebacate, dimethyl terephthalate, di (2-ethylhexyl) phthalate, and di-n-octyl phthalate;
- trimellitic acid monomer Butyl and mono-n-butyl trimellitate As tricarboxylic acid monoester, trimellitic acid monomer Butyl and mono-n-butyl trimellitate;
- tricarboxylic acid diester examples include dimethyl trimellitate and dibutyl trimellitate;
- Tricarboxylic acid triesters include trimethyl ethyl trimellitate and tributyl trimellitate;
- dialcohol monoesters examples include ethylene glycol monostearate and propylene glycol monostearate;
- dialcohol diester examples include ethylene glycol distearate, propylene glycol distearate and the like.
- these lipid compounds may be liquid or solid at normal temperature.
- these lipid compounds act as a kind of plasticity or flexibility imparting agent for the polyhydroxyalkanoate. Some of these lipid compounds have an effect of lowering the melting point of the polyhydroxyalkanoate when mixed. Therefore, it is possible to lower the thermal processing temperature, and to avoid unnecessary thermal decomposition, that is, to improve the workability. Moreover, these These lipid compounds are generally economical because they are inexpensive.
- the content of such a lipid compound in the resin composition is from 0.01 to 60% by weight, preferably from 1 to 40% by weight. If the content of lunar substances is less than 0.01% by weight, the effect of improving the physical properties of polyhydroxyalkanoate cannot be sufficiently obtained, and if the content exceeds 60% by weight, The lipid compound causes phase separation and the like, and causes deterioration in physical properties of the obtained soft medical member.
- the method of mixing polyhydroxyalkanoate with these lipid compounds is as follows. Both are dissolved and mixed in a suitable solvent such as chloroform, methylene chloride, 1,2-dichloroethane, dioxane, and the like. A method of evaporating the post-solvent and a method of mixing the lipid compound while heating using a mixing roll or an extruder can be applied. '
- a composite material in which such a resin composition is mixed with another resin is also suitably applied.
- the resin that can be mixed is not particularly limited, and various known resins can be applied according to the desired properties. Specifically, polyethylene, polypropylene, polychlorinated vinyl, Polyvinyl acetate, ionomer, polyacrylic acid, polyacrylic acid ester, polymethacrylic acid, polymethacrylic acid ester, polyvinyl alcohol, polystyrene, polyvinylidene chloride, polyethylene terephthalate Preferred examples thereof include polybutylene terephthalate, nylon, polycarbonate, polyethylene glycol, polypropylene glycol, fluororesin, and copolymers thereof.
- the resin to be mixed with the above-mentioned resin composition is appropriately selected depending on desired properties. For example, by adding polyethylene terephthalate, mechanical durability can be imparted. By adding a fluororesin, water repellency or the like on the surface can be imparted.
- the content of the resin in the composite material is not particularly limited, but is usually about 1 to 70 wt%.
- various fillers, dyes, pigments, lubricants, antioxidants, stabilizers, etc. may be mixed as necessary. May be.
- the method of mixing the above-mentioned resin composition with these resins to form a composite material is not particularly limited, and a suitable solvent such as porcine form, methylene chloride, 1,2-dichloroethane, dioxane, etc. And a method in which both are dissolved and mixed in the mixture, and then the solvent is evaporated, and a method in which the mixture is mixed while heating using a mixing roll or an extruder. '
- the medical soft member of the present invention is at least smaller than the above-mentioned biodegradable resin composition or a composite material thereof with various resins (hereinafter, these are referred to as biodegradable materials). It is partly molded. .
- the shape is not limited at all, and includes a cylindrical body including a tube, a bag, a box, and a pillar! Any shape such as a dog, a cone, a film, a sheet, a thread, a woven or non-woven fabric, or an irregular shape such as various molded products may be used.
- -Applicable medical components include blood transfusion sets and transfusion Tubes in liquid sets, blood circuits, etc., connecting tubes, connecting tubes (connectors), branch tubes, drip tubes, octopus tubes, stopcocks, etc .;
- liquid bags such as blood bags, infusion bags, urinary bags, dialysate bags, enteral nutritional supplement bags, etc .;
- the medical soft member of the present invention since the medical soft member of the present invention has good biodegradability, it is suitably applied especially to disposable medical members.
- the medical soft member of the present invention does not need to be entirely formed of the above-mentioned biodegradable material, but only a part of these biodegradable materials, for example, only the balloon or tubular portion of a balloon catheter.
- the liquid bag may be formed of a biodegradable material, and the other parts may be formed of a normal resin, and other portions may be formed of a normal resin. It may be molded.
- a laminated material obtained by laminating the biodegradable material and a normal resin May be formed.
- the biodegradable material applied to the soft medical member of the present invention has thermoplasticity. Therefore, as a method for molding the soft medical member such as a tube or a bag according to the present invention, various ordinary resin processing methods can be applied, such as extrusion molding, injection molding, vacuum molding, and press molding. What is necessary is just to select the method according to a shape, a use, or the equipment used suitably. For example, it can also be made into a stable shape as shown in FIG. 3 by injection molding or the like.
- thermoplastic resin As a method for forming a biodegradable material applied to the soft medical member of the present invention into a thread, various methods for forming an ordinary thermoplastic resin into a thread can be used. It has a cylinder part and a die part heated to about 5 to 20 above the melting point of the biodegradable material, and can be formed into a monofilament or multifilament by an extruder. it can.
- the thread-shaped material according to the soft medical member of the present invention thus formed may not have sufficient strength when applied to a suture or the like. It is preferable to apply.
- the amorphous (amorphous) filamentous body of the present invention formed as described above is treated with a glass transition temperature (T g) and a melting point (T m). Axially at temperatures between An example is a method of improving the strength by stretching and orienting and further crystallization.
- a biodegradable material such as 1,2-dichloroethane or the like can be dissolved in a solvent capable of dissolving.
- a solution with a concentration of about 1% is extruded into a poor solvent such as ethanol, methanol or n-hexane from a nozzle such as a syringe, and the resin is solidified to form a thread. It is preferably applied.
- a processing method of dissolving in the above-mentioned solvent, dip coating, roll coating, or the like is also preferable. It can be applied appropriately.
- the resin composition used in the present invention has a melting point, it can be thermoformed like extrusion molding.
- a small, small-size extrusion molding machine made by Ooba Seisakusho
- a monohole die can be formed into a monofilament at a molding temperature of 5 to 20 plus the melting point.
- a multi-hole die with about six holes can be attached to form a multi-filament yarn.
- the material of the present invention is dissolved in chloroform-form dichloromethane, adjusted to a concentration of 2 to 5%, and injected into a solvent such as n-hexane, methyl alcohol, ethyl alcohol, or the like in the form of a syringe. It can also be formed into a thread by so-called wet spinning, in which the extruded polymer is solidified and formed into a thread.
- the obtained yarn can be formed into a knitting yarn using a knitting machine. Since the yarn formed by each forming method is in an amorphous state (amorphous state) immediately after forming, it is sufficient by stretching in the axial direction of the yarn at a temperature above the glass transition temperature (Tg) and above. Completely by maintaining the stretching state as it is until crystallization proceeds The film is stretched and oriented to obtain a suture with sufficient strength.
- These yarns can be subjected to a treatment applied to a known suture such as surface treatment such as coating the surface with calcium stearate. Further, a suture needle can be attached by a method such as fitting to form a suture with a needle.
- a treatment applied to a known suture such as surface treatment such as coating the surface with calcium stearate.
- a suture needle can be attached by a method such as fitting to form a suture with a needle.
- the material of the present invention has a melting point and can be thermoformed, but the molding temperature is set to the melting point plus 10 to 30. By increasing the height of C, injection molding into a stable and clip having a desired shape is possible.
- the medical soft member of the present invention molded in this manner is sterilized and applied to a predetermined use.
- the sterilization method is not particularly limited, and it includes autoclave sterilization, ultraviolet sterilization, and X-ray sterilization. Sterilization by ionizing radiation such as electron beams, gas depletion by ethylene oxide, etc. Various known sterilization methods such as sterilization with bacteria using alcohol or the like may be used.
- the obtained sheet is cut with a cutter to produce a pellet, and using this pellet as a raw material, a die temperature of 1750 ° C is used with an extruder plastic mill (manufactured by Toyo Seiki Seisaku-sho, Ltd.). Extrusion was performed at C to obtain a tube with an outer diameter of 6 mm and an inner diameter of 4 mm.
- the obtained tube was a flexible tube with strong stiffness.
- an infusion set 10 as shown in FIG. 4 was assembled.
- the soft tube 12 is a soft tube made of the soft medical member of the present invention, and the other members are conventional members. This was placed in a conventional packaging bag, sealed, and then sterilized by irradiating 1 Mrad of X-rays with cobalt 60 as a radiation source.
- the infusion set 10 after use was buried in the soil of Nakai-cho, Ashigara-kami-gun, Kanagawa Prefecture and excavated six months later.
- the soft tube 12 made of the medical soft member of the present invention was completely disassembled to keep its original shape. Was not.
- the glycerol trilaurate was glycerol triacetate (manufactured by Tokyo Chemical Industry Co., Ltd.), and the mixing ratio with poly (3-hydroxybutyrate) was 70:30.
- This pellet was used as a raw material, and an example was performed at a die temperature of 160.
- a soft tube having an outer diameter of 6 mm and an inner diameter of 4 mm was obtained in the same manner as in 1. No trouble occurred during molding, and the obtained soft tube was a flexible tube with high flexibility.
- Example 2 Using this flexible tube, an infusion set similar to that of Example 1 was prepared, and a similar experiment was performed. As a result, there was no problem in use, and after 6 months in the soil, the flexible tube was used. Although it had not been completely disassembled and remained in its original form, the parts composed of conventional members such as bottle needles, drip tubes, and creme were in their original form.
- a tube was prepared in the same manner as in Example 1 except that glycerol trilaurate was not used. However, the obtained tube was inflexible and was easily broken. I could not assemble.
- an inflation molding die was attached to the same extruded Zen as in Example 1, and the die temperature was 1.65. Inflation molding was performed at ° C to obtain a sheet having a thickness of 0.4 mm, which was processed into a soft bag 14 as shown in FIG. 5 by a heat sealing method.
- the connected tube used was the one prepared in Example 2. '
- This soft bag 14 was filled with 100 ml of physiological saline (Terumo raw food made by Terumo Corporation), and this was autoclaved with 121 for 20 minutes.
- the soft pug 14 also maintained its flexibility, and was in a state of being sufficiently durable for normal use.
- the physiological saline was discharged, and the soft bag 14 was buried in the soil of Nakai-cho, Ashigarakami-gun, Kanagawa Prefecture, and when it was dug up six months later, it had not completely disassembled and retained its original shape.
- Example 3 100 parts by weight of straight chloride chloride (Kanegafuchi Chemical Co., Ltd. S 1001), 50 parts by weight of dioctyl phthalate, and other antioxidants, etc. as usual Similar to Example 3 Soft polyvinyl chloride sheet was obtained by inflation molding. This soft polyvinyl chloride sheet was applied with a high-frequency seal to obtain a soft bag similar to that shown in FIG.
- the obtained soft bag was buried in the same soil as in Example 3 and dug up six months later, and no particular change in appearance was observed.
- the resulting soft bag was stronger than the one in Example 3 and was harder to be torn, and the surface was not easily damaged.
- Example 6 After the contents were discharged, the soft bag was buried in the same soil as in Example 1 for 6 months. However, a small amount of powder that was considered to be polyethylene terephthalate was found. [Example 6]
- the sheet was melted, mixed, and then evaporated to form a 2-mm-thick sheet.
- the obtained sheet was cut with a cutter to produce a pellet, and the pellet was used as a raw material in a small small-size extruder (manufactured by Powova Seisakusho) to obtain a temperature of part of the cylinder of 178 ° C.
- a small small-size extruder manufactured by Powova Seisakusho
- the product was extruded from a nozzle having an inner diameter of 0.5 mm to obtain a filament.
- the resulting filament was immediately quenched with liquid nitrogen.
- the quenched filament was then stretched using a stretching apparatus at room temperature (approximately 29 ° C.) to just before breaking, to a length of at least 10 times.
- a flexible suture having an outer diameter of 0.1 was obtained in the same manner as in Example 6 except that glycerol tributyrate was replaced with glycerol tricaprate (manufactured by Tokyo Chemical Industry Co., Ltd.).
- a flexible suture having an outer diameter of 0.11 mm was obtained in the same manner as in Example 6 except that glycerol monostearate (manufactured by Tokyo Chemical Industry Co., Ltd.) was used instead of glycerol tributyrate.
- the fur-like material was inserted into the rat abdominal cavity so as to come into contact with the organ, but no problem occurred in the rat even after one month.
- Example 7 1.0 g of the pellets prepared in the same manner as in Example 7 was dissolved in a 30-ml black-mouthed form, and a cast film having a thickness of 0.6 mra was prepared on a petri dish. The cast film was cut into a size of 30 ⁇ 30, sterilized by EOG, and then inserted between the wound of the skin and the intestine in the abdominal cavity of the rat to form an adhesion preventing film.
- the medical soft member of the present invention has excellent biodegradability by using a predetermined resin composition having good biodegradability as a material, and is sterilized after use and disposed in a landfill or under the sea. By leaving them in the environment, they will not decompose in a short time and cause environmental pollution.
- Material-Suitable for use as an implantable material in vivo is excellent in processability, economic efficiency, ecosystem and biocompatibility, etc., so it can be used for various medical applications, especially disposable medical soft parts.
- Material-Suitable for use as an implantable material in vivo is excellent in processability, economic efficiency, ecosystem and biocompatibility, etc., so it can be used for various medical applications, especially disposable medical soft parts.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/066,015 US5480394A (en) | 1991-09-27 | 1992-06-11 | Flexible member for use as a medical bag |
EP92911236A EP0560984B1 (en) | 1991-09-27 | 1992-06-11 | Flexible member for medical use |
DE69229261T DE69229261T2 (de) | 1991-09-27 | 1992-06-11 | Flexibles teil zur medizinischen verwendung |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3249446A JPH05159A (ja) | 1990-09-27 | 1991-09-27 | 医療用軟質部材 |
JP3/249446 | 1991-09-27 | ||
JP3/298959 | 1991-11-14 | ||
JP3298959A JPH05131023A (ja) | 1991-11-14 | 1991-11-14 | 生体内埋込材料およびそれを用いた医療用具 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993005824A1 true WO1993005824A1 (en) | 1993-04-01 |
Family
ID=26539291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1992/000749 WO1993005824A1 (en) | 1991-09-27 | 1992-06-11 | Flexible member for medical use |
Country Status (4)
Country | Link |
---|---|
US (1) | US5480394A (ja) |
EP (1) | EP0560984B1 (ja) |
DE (1) | DE69229261T2 (ja) |
WO (1) | WO1993005824A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010081687A (ko) * | 2000-02-18 | 2001-08-29 | 윤여생 | 생분해성 수액셋트 |
US7553923B2 (en) | 1999-03-25 | 2009-06-30 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US7641825B2 (en) | 2004-08-03 | 2010-01-05 | Tepha, Inc. | Method of making a polyhydroxyalkanoate filament |
US9125719B2 (en) | 2003-05-08 | 2015-09-08 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
US9555155B2 (en) | 2014-12-11 | 2017-01-31 | Tepha, Inc. | Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof |
US10500303B2 (en) | 2014-08-15 | 2019-12-10 | Tepha, Inc. | Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof |
US10626521B2 (en) | 2014-12-11 | 2020-04-21 | Tepha, Inc. | Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof |
CN119081201A (zh) * | 2024-11-08 | 2024-12-06 | 江苏爱舍伦医疗科技集团股份有限公司 | 一种子母式储尿袋的制备方法 |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2281709B (en) * | 1993-09-14 | 1998-04-08 | Fujitsu Ltd | Biodegradable resin moulded article |
DE4418634C2 (de) * | 1993-09-14 | 2001-08-30 | Fujitsu Ltd | Aus bioabbaubarem Harz geformter Artikel, Modifikationsverfahren eines Harzes, Harzzusammensetzung und geformter Harzartikel |
KR100256855B1 (ko) * | 1995-08-02 | 2000-05-15 | 모리시타 요이찌 | 구조재 및 이를 사용하는 성형체 및 이들의 분해처리 방법 |
US5942597A (en) * | 1995-08-21 | 1999-08-24 | The Procter & Gamble Company | Solvent extraction of polyhydroxyalkanoates from biomass |
US5738671A (en) * | 1996-07-30 | 1998-04-14 | Bracco Diagnostics Inc. | Flexible plastic container for the containment and delivery of diagnostic contrast media and parenteral drug formulations |
USD395136S (en) | 1996-10-29 | 1998-06-16 | Bracco Diagnostics, Inc. | Flexible medical fluid container |
AU7486798A (en) * | 1997-05-12 | 1998-12-08 | Metabolix, Inc. | Polyhydroxyalkanoates for (in vivo) applications |
JP2002516384A (ja) * | 1998-05-22 | 2002-06-04 | メタボリックス,インコーポレイテッド | ポリヒドロキシアルカノエートバイオポリマー組成物 |
DE10122128A1 (de) * | 2001-04-27 | 2002-11-07 | Inst Polymerforschung Dresden | Resorbierbares Patch-Implantat, Verfahren zu seiner Herstellung und Verwendung |
US7322961B2 (en) * | 2003-01-15 | 2008-01-29 | I-Flow Corporation | Seal assembly for elastomeric infusion pump |
WO2004108200A1 (en) * | 2003-06-05 | 2004-12-16 | Js Vascular, Inc. | Surgical drains |
ES2395077T3 (es) * | 2003-07-08 | 2013-02-08 | Tepha, Inc. | Matrices poli-4-hidroxibutirato para una administración prolongada de medicamentos |
AU2004268560B2 (en) * | 2003-08-22 | 2008-08-21 | Tepha, Inc. | Polyhydroxyalkanoate nerve regeneration devices |
US20050249899A1 (en) * | 2004-05-06 | 2005-11-10 | Bonutti Peter M | Biodegradable packaging material |
ATE481088T1 (de) * | 2005-01-28 | 2010-10-15 | Tepha Inc | Embolisierung unter verwendung von poly-4- hydroxybutyrat-partikeln |
US8052637B2 (en) | 2005-07-12 | 2011-11-08 | Abbott Laboratories | Medical device balloon |
WO2007144427A2 (en) * | 2006-06-15 | 2007-12-21 | As Ldiamon | Container, system and method for providing a solution |
US7943683B2 (en) * | 2006-12-01 | 2011-05-17 | Tepha, Inc. | Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers |
US9555167B2 (en) * | 2006-12-11 | 2017-01-31 | 3M Innovative Properties Company | Biocompatible antimicrobial compositions |
US20080200890A1 (en) * | 2006-12-11 | 2008-08-21 | 3M Innovative Properties Company | Antimicrobial disposable absorbent articles |
US9457172B2 (en) * | 2008-01-28 | 2016-10-04 | Peter Forsell | Blood clot removal device, system, and method |
ES2817544T3 (es) | 2008-05-06 | 2021-04-07 | Cj Cheiljedang Corp | Mezclas de poliéster biodegradables |
CA2740875A1 (en) * | 2008-10-15 | 2010-04-22 | Symbios Medical Products, Llc | Electronic flow control |
DE202010010668U1 (de) * | 2010-07-26 | 2011-11-16 | Rehau Ag + Co. | Schlauchleitung, insbesondere für Sanitäranwendungen, sowie Schlauchanordnung |
CN104755538B (zh) | 2012-08-17 | 2018-08-31 | Cj 第一制糖株式会社 | 用于聚合物共混物的生物基橡胶改性剂 |
EP3004225A1 (en) | 2013-05-30 | 2016-04-13 | Metabolix, Inc. | Recyclate blends |
EP3122817B1 (en) | 2014-03-27 | 2020-07-29 | CJ CheilJedang Corporation | Highly filled polymer systems |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59100131A (ja) * | 1982-11-12 | 1984-06-09 | アメリカン・サイアナミド・カンパニ− | ポリ(グリコ−ル酸)/ポリ(アルキレングリコ−ル)ブロツク共重合体及びその製造方法 |
JPS618107A (ja) * | 1984-06-22 | 1986-01-14 | Mitsubishi Rayon Co Ltd | 微多孔質膜の製造法 |
JPS6382665A (ja) * | 1986-09-29 | 1988-04-13 | 株式会社 カナエ | 医療用プラスチツク容器 |
JPS6448820A (en) * | 1987-08-18 | 1989-02-23 | Mitsubishi Chem Ind | Polyester copolymer and its production |
JPH02209918A (ja) * | 1989-02-09 | 1990-08-21 | Nippon Shoji Kk | ヒドロキシカルボン酸共重合体 |
JPH03187386A (ja) * | 1989-11-11 | 1991-08-15 | Boehringer Ingelheim Kg | 4―ヒドロキシアルカン酸を繰り返し単位とするポリエステル及びその製造方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3528165C2 (de) * | 1985-08-06 | 1994-07-07 | Roehm Gmbh | Mittels vernetzter Perlen eingetrübte Kunststoffelemente |
US5226564A (en) * | 1986-11-28 | 1993-07-13 | E. R. Squibb & Sons, Inc. | Manufacture of bags |
EP0288908B1 (en) * | 1987-04-28 | 1992-10-21 | Mitsubishi Gas Chemical Company, Inc. | Process for production of a random copolymer comprising d-(-)-3-hydroxybutyrate units and d-(-)-3-hydroxyvalerate |
JPS63269989A (ja) * | 1987-04-28 | 1988-11-08 | Yoshiharu Doi | 共重合体の製造法 |
DE69118622T2 (de) * | 1990-09-04 | 1996-09-19 | Nippon Synthetic Chem Ind | Biologisch abbaubare, schmelzgeformte Gegenstände, Laminate daraus und ihre Verwendung |
JPH04136066A (ja) * | 1990-09-27 | 1992-05-11 | Terumo Corp | 包装材 |
JPH04136067A (ja) * | 1990-09-27 | 1992-05-11 | Terumo Corp | 包装材 |
US5195987A (en) * | 1991-08-16 | 1993-03-23 | Karpiak Kenneth D | Emergency I.V. set-up apparatus |
-
1992
- 1992-06-11 US US08/066,015 patent/US5480394A/en not_active Expired - Lifetime
- 1992-06-11 DE DE69229261T patent/DE69229261T2/de not_active Expired - Fee Related
- 1992-06-11 WO PCT/JP1992/000749 patent/WO1993005824A1/ja active IP Right Grant
- 1992-06-11 EP EP92911236A patent/EP0560984B1/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59100131A (ja) * | 1982-11-12 | 1984-06-09 | アメリカン・サイアナミド・カンパニ− | ポリ(グリコ−ル酸)/ポリ(アルキレングリコ−ル)ブロツク共重合体及びその製造方法 |
JPS618107A (ja) * | 1984-06-22 | 1986-01-14 | Mitsubishi Rayon Co Ltd | 微多孔質膜の製造法 |
JPS6382665A (ja) * | 1986-09-29 | 1988-04-13 | 株式会社 カナエ | 医療用プラスチツク容器 |
JPS6448820A (en) * | 1987-08-18 | 1989-02-23 | Mitsubishi Chem Ind | Polyester copolymer and its production |
JPH02209918A (ja) * | 1989-02-09 | 1990-08-21 | Nippon Shoji Kk | ヒドロキシカルボン酸共重合体 |
JPH03187386A (ja) * | 1989-11-11 | 1991-08-15 | Boehringer Ingelheim Kg | 4―ヒドロキシアルカン酸を繰り返し単位とするポリエステル及びその製造方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0560984A4 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7553923B2 (en) | 1999-03-25 | 2009-06-30 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
KR20010081687A (ko) * | 2000-02-18 | 2001-08-29 | 윤여생 | 생분해성 수액셋트 |
US9125719B2 (en) | 2003-05-08 | 2015-09-08 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
US9333066B2 (en) | 2003-05-08 | 2016-05-10 | Tepha, Inc. | Method of making a medical textile from polyhydroxyalkanoate fibers |
US10111738B2 (en) | 2003-05-08 | 2018-10-30 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
US10136982B2 (en) | 2003-05-08 | 2018-11-27 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
US10314683B2 (en) | 2003-05-08 | 2019-06-11 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
US7641825B2 (en) | 2004-08-03 | 2010-01-05 | Tepha, Inc. | Method of making a polyhydroxyalkanoate filament |
US11426484B2 (en) | 2014-08-15 | 2022-08-30 | Tepha, Inc. | Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof |
US11944709B2 (en) | 2014-08-15 | 2024-04-02 | Tepha, Inc. | Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof |
US10500303B2 (en) | 2014-08-15 | 2019-12-10 | Tepha, Inc. | Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof |
US10227713B2 (en) | 2014-12-11 | 2019-03-12 | Tepha, Inc. | Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof |
US10626521B2 (en) | 2014-12-11 | 2020-04-21 | Tepha, Inc. | Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof |
US10590566B2 (en) | 2014-12-11 | 2020-03-17 | Tepha, Inc. | Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof |
US11828006B2 (en) | 2014-12-11 | 2023-11-28 | Tepha, Inc. | Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof |
US9555155B2 (en) | 2014-12-11 | 2017-01-31 | Tepha, Inc. | Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof |
CN119081201A (zh) * | 2024-11-08 | 2024-12-06 | 江苏爱舍伦医疗科技集团股份有限公司 | 一种子母式储尿袋的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP0560984A4 (en) | 1994-07-06 |
DE69229261D1 (de) | 1999-07-01 |
DE69229261T2 (de) | 1999-11-04 |
US5480394A (en) | 1996-01-02 |
EP0560984A1 (en) | 1993-09-22 |
EP0560984B1 (en) | 1999-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993005824A1 (en) | Flexible member for medical use | |
DE69836439T2 (de) | Polyhydroxyalkanoatzusammensetzungen mit kontrollierten abbaugeschwindigkeiten | |
Mathuriya et al. | Polyhydroxyalkanoates: biodegradable plastics and their applications | |
Ikada et al. | Biodegradable polyesters for medical and ecological applications | |
DE60036863T2 (de) | Medizinische vorrichtungen und verwendungen von polyhydroxyalkanoatpolymeren | |
EP0628586B1 (en) | Hydroxyalkanoate-polymer composition | |
US6828357B1 (en) | Polyhydroxyalkanoate compositions having controlled degradation rates | |
Shekhar et al. | Synthesis, properties, environmental degradation, processing, and applications of Polylactic Acid (PLA): an overview | |
JPH04335060A (ja) | 熱可塑性分解性ポリマー組成物 | |
NZ230246A (en) | Biodegradable polyester compositions containing lactide polymers | |
JP2013124424A (ja) | 生分解性脂肪族ポリエステル繊維から形成される抗菌性不織布、及び抗菌方法 | |
EP2536789A2 (en) | Polylactide hydrosol and articles made therefrom | |
Rahman et al. | Importance of sustainable polymers for modern society and development | |
CN109294070A (zh) | 一种可快速降解的聚烯烃组合物及其制备方法 | |
EP1292629B1 (en) | Glove comprising a polyhydroxyalkanoate | |
Cipurković et al. | Biodegradable Polymers: Production, properties and application in medicine | |
Adamus et al. | Degradation of nerve guidance channels based on a poly (L-lactic acid) poly (trimethylene carbonate) biomaterial | |
Kaith et al. | Environment benevolent biodegradable polymers: Synthesis, biodegradability, and applications | |
Asrar et al. | Biosynthetic processes for linear polymers | |
JPH05159A (ja) | 医療用軟質部材 | |
Hashim | Bioinspired materials: Polyhydroxyalkanoates-based graphene nanocomposites | |
EP0826803A2 (en) | Biodegradable polyester fiber | |
JP2004204195A (ja) | 生分解性成形物及びその製造方法 | |
WO1988004557A1 (en) | Implantable devices having hydrophobic component | |
JP2005041980A (ja) | 樹脂用可塑剤及び該可塑剤を含む樹脂組成物、並びに、該樹脂組成物を成形してなる成形体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BE DE FR GB IT NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08066015 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992911236 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992911236 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1992911236 Country of ref document: EP |